Sabalbaro, Amor T.
HRN: 21-49-04 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/21/2022
CEFUROXIME 500MG (TAB)
08/21/2022
08/28/2022
PO
500mg
Q12
Uti
Waiting Final Action
08/21/2022
CEFUROXIME 500MG (TAB)
08/21/2022
08/28/2022
PO
500mg
Q12
Uti
Waiting Final Action